Michael Bavaro - 28 Feb 2025 Form 4 Insider Report for Option Care Health, Inc. (OPCH)

Role
Chief Human Resources Officer
Signature
/s/ Sarah Kim, attorney-in-fact for Mr. Bavaro
Issuer symbol
OPCH
Transactions as of
28 Feb 2025
Net transactions value
-$656,060
Form type
4
Filing time
03 Mar 2025, 17:52:17 UTC
Previous filing
26 Feb 2025
Next filing
19 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPCH Common Stock Options Exercise $23,257 +1,226 +2% $18.97 62,457 28 Feb 2025 Direct
transaction OPCH Common Stock Options Exercise $231,080 +8,974 +14% $25.75 71,431 28 Feb 2025 Direct
transaction OPCH Common Stock Options Exercise $51,586 +2,153 +3% $23.96 73,584 28 Feb 2025 Direct
transaction OPCH Common Stock Options Exercise $68,860 +2,386 +3.2% $28.86 75,970 28 Feb 2025 Direct
transaction OPCH Common Stock Sale $1,030,843 -30,996 -41% $33.26 44,974 28 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -1,226 -100% $0.000000 0 28 Feb 2025 Common Stock 1,226 $18.97 Direct F2
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -8,974 -100% $0.000000 0 28 Feb 2025 Common Stock 8,974 $25.75 Direct F2
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -2,153 -50% $0.000000 2,153 28 Feb 2025 Common Stock 2,153 $23.96 Direct F3
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -2,386 -33% $0.000000 4,772 28 Feb 2025 Common Stock 2,386 $28.86 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of 30,996 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on February 28, 2025 with sale prices ranging from $33.25 to $33.285 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Fully vested.
F3 Stock options that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026.
F4 Stock options that vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date.